F

Farcast Biosciences

34 employees

Farcast develops a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
cancer
bispecifics
immune compartment
oncolytic virus
translational biology
preclinical drug testing
tumor micro environment
Health Diagnostics
I-O therapies
translational oncology
biopharmaceutical research
Health Care
monoclonal antibodies
immuno-oncology
Medical

Date founded

2019

Funding rounds raised

Total raised

$40M

from 6 investors over 6 rounds

F

Farcast Biosciences raised $40M on July 12, 2018

Investors: RA Capital Management, L.P., Northpond Ventures and Sands Capital Management

F

Farcast Biosciences raised $27M on August 29, 2016

Investors: RA Capital Management, L.P. and Sands Capital Management

F

Farcast Biosciences raised $2.2M on April 28, 2010

Investors: Karnataka Information Technology Venture Capital Fund

FAQ